Top Markets
Coin of the day
20/20 Biolabs Inc. 20/20 Biolabs Inc.

20/20 Biolabs Inc.

AIDX
Rank in Stocks #33864
20/20 GeneSystems, Inc. operates as a clinical laboratory testing company... 20/20 GeneSystems, Inc. operates as a clinical laboratory testing company focused on cancer screening and viral testing services. The company provides multi-cancer early detection blood testing, including a test called OneTest, and offers viral testing services such as rapid COVID-19 test kits, including the Assure COVID-19 IgG/IgM rapid test. It operates the Clinical Lab Innovation Axcelerator (CLIAx), a shared laboratory facility that supports diagnostic test developers in bringing products to the U.S. market. The company also delivers its cancer screening algorithm technology through a software as a service (SaaS) platform in partnership with healthcare providers and supports diagnostic startups by offering access to shared laboratory space and resources. The company was founded in 2000 and is based in Gaithersburg, Maryland.
Share Price
$0.5475
Last synced: 2026-08-14
Market Cap
$6.71M
Change (1 day)
5.57%
Change (1 year)
-
Country
US
Trade 20/20 Biolabs Inc. (AIDX)

Category

Stock split history for 20/20 Biolabs Inc. (AIDX)
20/20 Biolabs Inc. stock (symbol: AIDX) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 17, 2026.
One AIDX share bought prior to Aug 17, 2026 would equal to 0 AIDX shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors